| Molecular formula | C39H54N10O10S |
| Molecular weight | 855 g/mol |
| Registered trials | 0 |
| PubChem CID | 172638603 |
Anyone researching N-Acetyl Semax will quickly notice it has no approved medical use and no drug label. This overview covers only what is verifiable: its chemical identity and its presence, or absence, in registered clinical trials.
Regulatory status
N-Acetyl Semax is an unapproved research compound. It does not carry an FDA-approved label, and no indications, mechanism of action, or dosing information have been established through an approved regulatory pathway.
What N-Acetyl Semax is
N-Acetyl Semax is a synthetic peptide with the molecular formula C39H54N10O10S and a molecular weight of approximately 855 g/mol. It is catalogued in PubChem under CID 172638603. Beyond this chemical identity, no approved labeling exists to describe how the compound behaves in the body.
Clinical trial footprint
There are no registered clinical trials for N-Acetyl Semax at this time. No trial data, phase information, or study results are available to describe or summarize.
FAQ
No. N-Acetyl Semax has no FDA-approved label and is classified as an unapproved research compound. No approved indications or mechanism of action have been established.
It is a synthetic peptide with the molecular formula C39H54N10O10S and a molecular weight of about 855 g/mol. It is listed in PubChem under CID 172638603.
There are currently no registered clinical trials for N-Acetyl Semax. No study data or trial results are available to summarize.
No side effect reports are available for this compound. Without an approved label or trial data, no adverse event pattern can be described.
No approved medical use exists for N-Acetyl Semax. It remains an unapproved research substance with no established clinical application.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 172638603 ClinicalTrials.gov registry count
Updated 2026-08-10